annual meeting program - American Society of Clinical Oncology

Sunday, June 6, 2010
Brd. 27D Vinorelbine and cisplatin concurrently combined with thoracic radiotherapy
in patients with unresectable stage III non-small cell lung cancer: A long-term
safety and efficacy report. (Abstract #7088)
H. Horinouchi, I. Sekine, M. Sumi, K. Noda, Y. Nishiwaki, K. Mori, T. Tamura
Brd. 27E Can we predict 2-year survival for radical radiation dosing schedules in
advanced non-small cell lung cancer through a meta-analysis based
predictive model? (Abstract #7089)
W. Sharieff
Brd. 27F Docetaxel (D) and cisplatin (C) induction chemotherapy followed by
concurrent thoracic radiotherapy (TRT) and biweekly D and C for stage III
non-small cell lung cancer (NSCLC): A Galician Lung Cancer Group study.
(Abstract #7090)
J. Casal, S. Varela, U. Anido, M. Lázaro, J. L. Fírvida, S. Vazquez-Estevez,
M. Villanueva, M. Amenedo, M. Caeiro, A. Gomez
Brd. 27G A Galician Lung Cancer Group phase II study: Erlotinib as maintenance
therapy after concurrent chemoradiotherapy in patients (p) with stage III
non-small cell lung cancer (NSCLC). (Abstract #7091)
S. Vazquez, J. Firvida, M. Lázaro, F. J. Barón, G. Alonso-Jaudenes Curbera,
M. Amenedo, L. Santomé, F. J. Afonso, J. V. Cardona, J. Casal
Brd. 27H Concomitant pemetrexed/carboplatin chemotherapy and 3D conformal
radiotherapy followed by pemetrexed/carboplatin consolidation
chemotherapy for locally advanced non-small cell lung cancer: Preliminary
results of a phase II study. (Abstract #7092)
S. Ma, Y. Xu, Y. Ji, X. Sun, J. Cheng, X. Du, Y. Zheng, G. Qiu
Brd. 28A Cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with
radiotherapy (RT) after induction chemotherapy (CT) in locally advanced (LA)
non-small cell lung cancer (NSCLC) treatment: Clinical experience in five
institutions in Spain. (Abstract #7093)
J. Remon, I. Diaz Padilla, J. Andrade, A. Gasco, J. M. Jurado, F. J. Perez,
M. P. Lianes
Brd. 28B Outcomes of patients with stage III (clinical N2) NSCLC: A VACCR analysis.
(Abstract #7094)
A. Ganti, W. Gonsalves, I. Aldoss, F. R. Loberiza Jr.
Brd. 28C Retrospective review of all patients with thymoma treated over the last 33
years at the Royal Marsden Hospital. (Abstract #7095)
C. Benson, R. S. Kristeleit, S. Ashley, S. Dolly, C. Mikropoulos, M. O’Brien,
S. Popat
Brd. 28D Volumetric analysis of advanced thymic malignancies. (Abstract #7096)
J. Force, A. Rajan, E. Dombi, S. M. Steinberg, G. Giaccone
Brd. 28E Clinical features of bronchioloalveolar carcinoma with new histologic and
staging definitions. (Abstract #7097)
P. Yang, J. Ebbert, L. Chhatwani, J. A. Wampfler, S. Stoddard, F. Zhang,
M. de Andrade, M. Aubry
Brd. 28F Baseline results of lung cancer screening program for family lung cancer
risk with low-dose spiral CT in Taiwan. (Abstract #7098)
C. Wang, Y. Tsai, Y. Cheung, H. Ko, Y. Ni, P. Feng, Y. Chen, P. Yang, G. Chang
213
SUNDAY